Picture of Dice Therapeutics logo

DICE — Dice Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Dice Therapeutics Reports Q4 And Full Year 2022 Financial Results And Recent Highlights

March 15 (Reuters) - Dice Therapeutics Inc  DICE.O :
    * DICE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND RECENT HIGHLIGHTS
    * ENDED 2022 WITH $574.2 MILLION IN CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES, PROVIDING RUNWAY INTO 2026
    * QTRLY  LOSS PER SHARE $0.51
    * Q4 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX97dgFc 
Further company coverage:  DICE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dice Therapeutics

See all news